/ About this event
The GTM playbook looks very different when you’re trying to find your first 100 patients versus trying to scale to the next 10,000.
For early-stage telehealth companies, the hard questions are rarely just “how do we lower CAC?” They’re more like: - Which channel should we bet on before we have enough data? - What should we optimize for — lead, booked consult, prescription, or retained patient? - When does paid acquisition become a trap? - How much does trust actually move conversion in healthcare? - Where is the real drop-off — ad → landing page, intake → booking, consult → treatment, or month 1 → month 3? - When should you invest in brand versus performance? - What does good LTV:CAC even mean when adherence determines LTV? - How do you know whether you have a marketing problem, a conversion problem, or a care-delivery problem? - What should a founder instrument from day one so they can actually understand the funnel? - Where can AI meaningfully improve acquisition, conversion, follow-up and retention — and where is it just another tool?
Hosted by SuperDerma AI, this conversation is for founders and operators building across teledermatology, GLP-1s, peptides, longevity and other direct-to-patient healthcare businesses, particularly those navigating the 0→1 and 1→10 journey.
We’ll break down the full patient funnel: Attention → Trust → Lead → Intake → Consultation → Conversion → Treatment → Adherence → Repeat and talk about what actually changes as a telehealth company moves from finding product-market fit to building a repeatable growth engine.
The goal is not another panel on “growth hacks.” It’s to answer a more useful question: What should a telehealth founder actually build, measure and optimize at each stage of growth?
This event is a part of #SFTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.
